退行性后叶脱垂二尖瓣修复:叶瓣切除与保留技术的比较
本研究比较后叶脱垂二尖瓣修复中叶瓣切除与人工腱索植入两种技术,纳入639例患者(切除组479例,人工腱索组160例)。中位随访97.3个月,两组死亡和再手术风险无显著差异,跨瓣压差相当,但人工腱索组显著二尖瓣反流复发概率更高(5年时16.1% vs 7.0%,P < .001)。
要点
- 叶瓣切除与人工腱索植入术后死亡和再手术风险无显著差异。
- 两组平均和峰值跨瓣压差相当,多数亚组分析结果一致。
- 人工腱索组5年显著二尖瓣反流复发率16.1%,高于叶瓣切除组的7.0%。
核心结论
- 叶瓣切除与人工腱索植入在二尖瓣修复后临床结局和跨瓣压差相似,但叶瓣切除的反流复发率更低。
研究设计与样本
- 单中心研究,纳入2000年至2021年因后叶单段脱垂行二尖瓣修复的患者639例。
- 采用逆概率治疗加权调整后评估纵向结局,并使用非线性混合效应模型分析重复超声测量数据(n = 3473,5.4次/患者)。
主要发现
- 叶瓣切除组479例(75.0%),人工腱索组160例(25.0%)。
- 中位随访97.3个月,逆概率治疗加权调整后两组死亡风险(P = .623)和二尖瓣再手术风险(P = .340)无显著差异。
- 5年时平均跨瓣压差叶瓣切除组3.8 mmHg vs 人工腱索组4.0 mmHg(P = .442),峰值压差9.6 vs 10.4 mmHg(P = .131)。
- 5年时显著二尖瓣反流复发概率人工腱索组16.1% vs 叶瓣切除组7.0%(P < .001)。
临床怎么用
- 对于后叶单段脱垂的二尖瓣修复,叶瓣切除在降低反流复发方面可能优于人工腱索植入。
- 研究结果提示需要重新评估人工腱索植入相对于叶瓣切除的疗效。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The optimal technique for repairing posterior mitral valve leaflet prolapse remains undetermined. We aimed to compare leaflet resection and neochordae implantation in patients undergoing mitral valve repair for posterior leaflet prolapse, focusing on transmitral pressure gradient and recurrence of mitral regurgitation. METHODS: We enrolled patients undergoing mitral valve repair using either leaflet resection or neochordae implantation for single-segment prolapse of posterior mitral valve leaflet between 2000 and 2021 at our institution. Longitudinal outcomes were evaluated after adjustments with inverse-probability-of-treatment weighting. Repeat echocardiographic measurements (n = 3473, 5.4/patient) of transmitral pressure gradient and significant (moderate or severe) mitral regurgitation recurrence were estimated using nonlinear mixed-effect models. Subgroup analyses were conducted based on the size and type of prosthesis. RESULTS: Among 639 patients, leaflet resection was used in 479 (75.0%) and neochordae implantation was used in 160 (25.0%). In the inverse-probability-of-treatment weighting adjusted cohort, the risk of death (P = .623) and mitral valve reoperation (P = .340) did not significantly differ between the 2 groups during a median follow-up of 97.3 months. Echocardiographic data showed comparable mean (at 5 years, 3.8 vs 4.0 mm Hg; P = .442) and peak (9.6 vs 10.4 mm Hg; P = .131) pressure gradients between groups, which persisted in most subgroup analyses. However, neochordae implantation was associated with a higher probability of significant mitral regurgitation recurrence compared with leaflet resection (at 5 years, 16.1% vs 7.0%; P < .001). CONCLUSIONS: Leaflet resection yielded similar clinical outcomes and transmitral pressure gradients compared with neochordae implantation after mitral valve repair, with a lower mitral regurgitation recurrence rate. These findings underscore the need to reassess the efficacy of neochordae implantation relative to leaflet resection.
引用
- Kwon Y, Kim HJ, Kim JB, et al. Mitral valve repair with leaflet resection versus preservation for degenerative posterior leaflet prolapse. J Thorac Cardiovasc Surg. 2024. PMID: 38964494. doi:10.1016/j.jtcvs.2024.06.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。